Kevin Bitterman, Director at Editas Medicine, Inc. (EDIT), sold 1,000,000 shares at $17.00 ($17.0M) on 2017-05-22, disclosed to the SEC on 2017-05-24.
Open-market sale of $17.0M EDIT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2026-09-03 | $4.4M | — | Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |